MannKind Corp
MNKD
#6456
Rank
A$1.08 B
Marketcap
A$3.53
Share price
3.38%
Change (1 day)
-55.86%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): A$48.59 Million

According to MannKind Corp's latest financial reports the company's current earnings are A$0.31 Billion. In 2024 the company made an earning of A$43.96 Million, an increase over its 2023 earnings that were of -A$14.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$48.59 M10.51%
2024 A$43.96 M-394.09%
2023 -A$14.96 Million-88.13%
2022 -A$0.13 Billion8%
2021 -A$0.12 Billion40.84%
2020 -A$82.79 Million10.7%
2019 -A$74.79 Million-40.16%
2018 -A$0.13 Billion-26.04%
2017 -A$0.17 Billion-193.33%
2016 A$0.18 B-134.11%
2015 -A$0.54 Billion85.72%
2014 -A$0.29 Billion3.6%
2013 -A$0.28 Billion12.79%
2012 -A$0.25 Billion5.58%
2011 -A$0.24 Billion-5.72%
2010 -A$0.25 Billion-22.51%
2009 -A$0.32 Billion-27.37%
2008 -A$0.44 Billion3.36%
2007 -A$0.43 Billion27.18%
2006 -A$0.34 Billion101.63%
2005 -A$0.17 Billion50.46%
2004 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.68 B 33,009.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$30.20 B 67,994.73%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$37.07 B 83,488.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.30 B 72,742.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$0.67 B 1,416.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-A$0.23 Billion-605.11%๐Ÿ‡บ๐Ÿ‡ธ USA